Clinical Trial for Stem Cell-Based ALS Treatment Shows Promise

Researchers who completed the first American clinical trial involving stem cell-based treatment of Amyotrophic Lateral Sclerosis (ALS) were encouraged by the trial study’s results, noting that this delivery approach could be a helpful therapeutic approach for other traumatic spine-related problems. The group focused on the safety of a direct microinjection-based technique and neural stem cell transplantation to the cervical and thoracolumbar spinal cord. Click here to read the full release.